Tudor Investment Corp ET AL Has $1.25 Million Stock Holdings in Avid Bioservices, Inc. (NASDAQ:CDMO)

Tudor Investment Corp ET AL raised its stake in shares of Avid Bioservices, Inc. (NASDAQ:CDMO) by 757.3% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 101,192 shares of the biopharmaceutical company’s stock after purchasing an additional 89,389 shares during the quarter. Tudor Investment Corp ET AL’s holdings in Avid Bioservices were worth $1,250,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors also recently modified their holdings of the company. HighTower Advisors LLC boosted its stake in Avid Bioservices by 23.3% in the 4th quarter. HighTower Advisors LLC now owns 13,861 shares of the biopharmaceutical company’s stock valued at $171,000 after buying an additional 2,620 shares in the last quarter. MetLife Investment Management LLC lifted its holdings in shares of Avid Bioservices by 7.8% during the fourth quarter. MetLife Investment Management LLC now owns 38,018 shares of the biopharmaceutical company’s stock valued at $470,000 after acquiring an additional 2,767 shares during the period. Zions Bancorporation N.A. boosted its stake in shares of Avid Bioservices by 2.7% in the 4th quarter. Zions Bancorporation N.A. now owns 107,141 shares of the biopharmaceutical company’s stock valued at $1,323,000 after purchasing an additional 2,815 shares in the last quarter. Rhumbline Advisers increased its position in shares of Avid Bioservices by 3.4% during the 4th quarter. Rhumbline Advisers now owns 94,700 shares of the biopharmaceutical company’s stock worth $1,170,000 after purchasing an additional 3,121 shares in the last quarter. Finally, R Squared Ltd bought a new position in Avid Bioservices during the 4th quarter valued at about $42,000. 97.16% of the stock is currently owned by institutional investors.

Avid Bioservices Stock Up 0.1 %

NASDAQ CDMO opened at $12.50 on Tuesday. The company has a debt-to-equity ratio of 3.58, a current ratio of 1.30 and a quick ratio of 0.92. The firm has a market cap of $799.18 million, a PE ratio of -5.23 and a beta of 1.39. The stock’s 50 day simple moving average is $12.50 and its 200 day simple moving average is $12.22. Avid Bioservices, Inc. has a one year low of $6.53 and a one year high of $12.51.

Avid Bioservices Profile

Avid Bioservices, Inc operates as a contract development and manufacturing organization for the biotechnology and biopharmaceutical industries in the United States. It provides process development and current good manufacturing practice clinical and commercial manufacturing services of biologics, including clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, regulatory submission and support, upstream and downstream development and optimization, analytical methods development, cell line development, testing, and characterization services.